Live Coronavirus, Spain, today
Restrictions "Going back to masks is counterproductive"
Interview "The situation in the ER may become unsustainable"
Ómicron
, the latest and worrying variant of SARS-CoV-2, has already been detected in
110 countries
and continues to spread exponentially, "doubling its cases in the communities where it is transmitted
in a matter of two or three days
." This was highlighted yesterday by the World Health Organization, which also reported that, in South Africa, the country that sounded the alarm about omicron, the rates of contagion of this variant are already falling.
The appearance of a variant of the coronavirus that leads us to an apocalyptic scenario is a fear that resurfaces periodically, as we are exhausting the Greek alphabet.
It is not yet clear what the
profile of this variant is
, although preliminary data show that it has a high transmission and reinfection capacity and perhaps greater mildness than its predecessors.
The latest analysis by the British Health Agency indicates that patients with omicron have a
50% to 70% lower
probability
of entering the hospital
compared to other versions of the coronavirus, such as delta.
The problem, they emphasize, is that its great ability to spread can compromise that apparent less aggressiveness.
In addition, to date, omicron has mainly affected young people, under 40 years of age, so there is no certainty as to what will happen in older age groups.
This analysis is in line with other work published this week by researchers from
Imperial College London
, which suggests that people infected with omicron are 40% less likely to be hospitalized for one night or more, compared to those who they become infected by the delta variant.
This multicenter study was carried out between December 1 and 14 on
56,000 people infected by omicron and 269,000 by delta.
Along this optimistic path, another work carried out by researchers from the University of Hong Kong pointed out that replication in human lung tissue was less efficient, about 10 times less than previous variants, but not the one that occurs in the bronchi (it multiplies 70 times faster than the delta variant and the Wuhan variant), which would point to milder symptoms but greater transmissibility.
Although it is natural to want to believe that the new variant is milder than the previous ones, in particular than the current dominant one, experts warn that these studies are still preliminary, and also that there are studies that would indicate a severity similar to that of delta.
Roger Paredes, head of the Department of Infectious Diseases and of the IrsiCaixa Institute for AIDS Research IrsiCaixa Hospital Universitari Germans Trias I Pujol de Badalona, comments “that the data are initial and there may be biases, because now omicron is circulating especially in the young population, among 20 and 30, which has a
lower risk of complications
.
In past waves we have already seen that problems come when older people start to get infected.
Still no certainties.
In addition, the severity of the variant may be attenuated by vaccination and previous infections ”.
At the moment, “
there are no studies that indicate that it is more serious than delta
.
In any case, the level of hospital saturation is guaranteed, if adequate measures are not taken, "says Paredes.
Because if something is evident, it is the accelerated growth of omicron throughout the world.
In Spain, the latest report from the Ministry indicates an almost 14-fold increase in omicron cases.
We have gone from 3.4% positive for the new variant among the samples sequenced from November 29 to December 5, to 47.2% in the week of December 6 to 12.
Paredes warns: "Even if the omicron variant was half as severe as delta, we would have many hospitalizations."
The omicron variant has found a way to break the barrier raised by covid vaccines (none of the available ones are sterilizing) or with previous natural infection by variant. This was highlighted by
Tedros Adhanom Ghebreyesus
, director general of the WHO, this week when noting that with omicron it is "more likely that people who have been vaccinated or have recovered from covid-19 can become infected or reinfected."
In a
preprint
study
(obviously the most abundant thing about omicron) researchers from the United Kingdom show that the efficacy of the two doses of the Pfizer-BioNTech mRNA vaccine drops to 40% at four months and is practically
non-existent
at 15 weeks from full AstraZeneca vaccine regimen. However, with the
booster dose of
the mRNA vaccine,
at two weeks
protection against symptomatic infection
associated with the new variant
was achieved
of
71%
in those who initially received AstraZeneca (heterologous vaccination) and
75%
, in those vaccinated with Pfizer.
Moderna 's
booster
also showed an increase in antibody titers, decreased between 41 and 84 times in the face of the new variant.
The company recently reported that the extra 50 g dose of its vaccine increases the levels of neutralizing antibodies against omicron by about 37 times, while a 100 g booster dose of mRNA-1273 increases it by 83 times.
There is no firm data yet on the extent to which the booster doses will have on omicron.
A small published study has reported the case of seven people who became infected with the new variant after receiving the third dose of an mRNA vaccine.
None had had a previous SARS-CoV-2 infection.
In Israel, where there has been a clear reduction in mortality from covid-19 -before the omicron irruption- thanks to the third injections, the administration of a
fourth dose
in people over 60 years old and in health professionals
has just been announced
.
Meanwhile, pharmaceutical companies are working on
adapting
their
vaccines
- both mRNA and adenoviral
vaccines
- to the new variant, although the
European Medicines Agency (EMA) is prudent when considering this measure necessary
. "Let me emphasize that there is
still no answer to the question of whether we
need a vaccine to measure, with a different composition, to combat this or any other variant ,
" the executive director of the EMA, said at a
news conference this week
Emer Cooke
, and added that receiving a booster is "the best protection at this time."
The EMA may be confident in the arrival of
second-generation vaccines
that are capable of inducing sterilizing immunity against any variant of the virus, such as the one being developed by the team led by Luis Enjuanes and Isabel Sola, at the Centro's Coronavirus Laboratory National of Biotechnology (CNB-CSIC).
According to the criteria of The Trust Project
Know more
Science and Health
Covid 19
Coronavirus
Omicron variant
HBPR
Covid-19 Omicron variant of the coronavirus: Are the symptoms more severe?
Are the vaccinated protected?
SATURATED NURSE Omicron symptoms: Muscle pain, fatigue and headache, but no loss of taste or smell
HealthThe macro outbreak of Malaga, a voice of alarm of what could happen after the Christmas holidays
See links of interest
Last News
What
2022 business calendar
Check Christmas Lottery
Covid passport
2021 Christmas Lottery Prizes
Loteria del Niño 2022
Second Prize Lottery 2021
El Gordo de la Loteria
Panathinaikos - Olympiacos Piraeus
Real Madrid - CSKA Moscow